CardioGenics Holdings (CardioGenics Holdings) Dividends per Share : $0.00 (TTM As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Dividends per Share?

CardioGenics Holdings's dividends per share for the three months ended in Jan. 2016 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jan. 2016 was $0.00. Its Dividend Payout Ratio for the three months ended in Jan. 2016 was 0.00. As of today, CardioGenics Holdings's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

CardioGenics Holdings Dividends per Share Historical Data

The historical data trend for CardioGenics Holdings's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Dividends per Share Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Dividends per Share

Get a 7-Day Free Trial

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CardioGenics Holdings's Dividends per Share

For the Diagnostics & Research subindustry, CardioGenics Holdings's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Dividend Yield % falls into.

CardioGenics Holdings Dividends per Share Calculation

Dividends paid to per common share.

CardioGenics Holdings (OTCPK:CGNH) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

CardioGenics Holdings's Dividend Payout Ratio for the quarter that ended in Jan. 2016 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jan. 2016 )	/	EPS without NRI (Q: Jan. 2016 )
	=	0	/	-0.003
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

CardioGenics Holdings Dividends per Share Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines